Interactions between the cells of the immune and nervous system: Neurotrophins as neuroprotection mediators in CNS injury

Progress in Brain Research

Volumn 146, Issue , 2004, Pages 385-401

  Tabakman, Rinat ^a   Lecht, Shimon ^a   Sephanova, Stela ^a   Arien Zakay, Hadar ^a   Lazarovici, Philip ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

BDNF; CNS injury; Inflammation; Lymphocytes; Neuroprotection; Neurotrophins; NGF; Trk

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; PROTEIN TYROSINE KINASE A; TYROSINE KINASE B; TYROSINE KINASE C; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; AUTOCRINE EFFECT; AUTOIMMUNITY; CELL FUNCTION; CELL INTERACTION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MEDIATOR; MULTIPLE SCLEROSIS; NERVE CELL; NERVOUS SYSTEM INJURY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OPTIC NERVE INJURY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

EID: 0346219194     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0079-6123(03)46024-x     Document Type: Conference Paper

References (115)

1. Aloe, L. and Levi-Montalcini, R. (1977) Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res., 133: 358-366.
2. Aloe, L. (1988) The effect of nerve growth factor and its antibody on mast cell in vivo. J. Neuroimmunol., 18: 1-12.
3. Aloe, L. and De Simone, R. (1989) NGF primed spleen cells injected in brain of developing rats differentiate into mast cells. Int. J. Devl. Neurosci., 7: 565-573.
4. Aloe, L. and Micera, A. (1999) Nerve growth factor: basic findings and clinical trials. Biomed. Rev., 10: 3-14.
5. Apfel, S.C. (1997) Clinical Applications of Neurotrophic Factors. Lippincott-Raven, Philadelphia, pp. 1-209.
6. Barbacid, M. (1995) Neurotrophic factors and their receptors. Curr. Opin. Cell Biol., 7: 148-155.
7. Barouch, R., Appel, E., Kazimirsky, G., Braun, A., Renz, H. and Brodie, C. (2000) Differential regulation of neurotrophin expression by mitogens and neurotransmitters in mouse lymphocytes. J. Neuroimmunol., 103: 112-121.
8. Barouch, R., Appel, E., Kazimirsky, G. and Brodie, C. (2001a) Macrophages express neutrophins and neutrophin receptors. Regulation of nitric oxide production by NT-3. J. Neuroimmunol., 112: 72-77.
9. Barouch, R., Kazimirsky, G., Appel, E. and Brodie, C. (2001b) Nerve growth factor regulates TNF-α production in mouse macrophages via MAP kinase activation. J. Leukoc. Biol., 69: 1019-1026.
10. Barouch, R. and Schwartz, M. (2002) Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J., 16: 1304-1306.
11. Batchelor, P.E., Liberatore, G.T., Wong, J.Y., Porritt, M.J., Frerichs, F., Donnan, G.A. and Howells, D.W. (1999) Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci., 19: 1708-1716.
12. Batchelor, P.E., Porritt, M.J., Martinello, P., Parish, C.L., Liberatore, G.T., Donnan, G.A. and Howells, D.W. (2002) Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol. Cell Neurosci., 21: 436-453.
13. Becher, B., Prat, A. and Antel, J.P. (2000) Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia, 29: 293-304.
14. Besser, M. and Wank, R. (1999) Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J. Immunol., 162: 6303-6306.
15. Bethea, J.R. and Dietrich, W.D. (2002) Targeting the host inflammatory response in traumatic spinal cord injury. Curr. Opin. Neurol., 15: 355-360.
16. Bischoff, S. and Dahinden, C. (1992) Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood, 79: 2662-2669.
17. Bonini, S., Lambiase, A., Bonini, S., Levi-Schaffer, F. and Aloe, L. (1999) Nerve growth factor: an important molecule in allergic inflammation and tissue remodelling. Int. Arch. Allergy Immunol., 118: 159-162.
18. Bracci-Laudiero, L., Aloe, L., Stenfors, C., Tirassa, P., Theodorsson, E. and Lundberg, T. (1996) Nerve growth factor stimulates production of neuropeptide Y in human lymphocytes. Neuroreport, 7: 485-488.
19. Brodie, C. and Gelfand, E.W. (1992) Functional nerve growth factor receptors on human B lymphocytes: interaction with IL-2. J. Immunol., 148: 3492-3497.
20. Brodie, C., Barouch, R., Appel, E. and Kazimirsky, G. (1999) Expression of neutrophins and neutrophin receptors on macrophages. Induction of nitric oxide and activation of signal transduction pathways. Neurosci. Lett. Suppl., 54: S10-S11.
21. Bruni, A., Bigon, E., Boarato, E., Mietto, L., Leon, A. and Toffano, G. (1982) Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells. FEBS Lett., 138: 190-193.
22. Canals, J.M., Checa, N., Marco, S., Akerud, P., Michels, A., Perez-Navarro, E., Tolosa, E., Arenas, E. and Alberch, J. (2001) Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area. J. Neurosci., 21: 117-124.
23. Carlson, S.L., Parrish, M.E., Springer, J.E., Doty, K. and Dossett, L. (1998) Acute inflammatory response in spinal cord following impact injury. Exp. Neurol., 151: 77-88.
24. Carlson, N.G., Wieggel, W.A., Chen, J., Bacchi, A., Rogers, S.W. and Gahring, L.C. (1999) Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J. Immunol., 163: 3963-3968.
25. Chao, M., Casaccia-Bonnefil, P., Carter, B., Chittka, A., Kong, H. and Yoon, S.O. (1998) Neurotrophin receptors: mediators of life and death. Brain Res. Rev., 26: 295-301.
26. Chao, M.V. and Bothwell, M. (2002) Neurotrophins: to cleave or not to cleave. Neuron, 33: 9-12.
27. Deigner, H.P., Haberkorn, U. and Kinscherf, R. (2000) Apoptosis modulators in the therapy of neurodegenerative diseases. Expert Opin. Investig. Drugs, 9: 747-764.
28. Dustin, M.L. and Colman, D.R. (2002) Neural and immunological synaptic relations. Science, 298: 785-789.
29. Ehrhard, P.B., Erb, P., Graumann, U. and Otten, U. (1993a) Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc. Natl. Acad. Sci. USA, 90: 10984-10988.
30. Ehrhard, P.B., Ganter, U., Bauer, J. and Otten, U. (1993b) Expression of functional trk protooncogene in human monocytes. Proc. Natl. Acad. Sci. USA, 90: 5423-5427.
31. Ehrhard, P.B., Erb, P., Graumann, U., Schmutz, B. and Otten, U. (1994) Expression of functional trk tyrosine kinase receptors after T cell activation. J. Immunol., 152: 2705-2709.
32. Faden, A.I. (1993) Experimental neurobiology of central nervous system trauma. Crit. Rev. Neurobiol., 7: 175-186.
33. Freidman, W.J. and Greene, L.A. (1999) Neurotrophin signaling via Trks and p75. Exp. Cell Res., 253: 131-142.
34. Friendl, P. and Gunzer, M. (2001) Interaction of T cells with APCs: the serial encounter model. Trends Immunol., 22: 187-191.
35. Galvin, K.A. and Jones, D.G. (2002) Adult human neural stem cells for cell-replacement therapies in the central nervous system. Med. J. Aust., 177: 316-318.
36. Garcia-Suarez, O., Hannestad, J., Esteban, I., Martinez del Valle, M., Naves, F.J. and Vega, J.A. (1997) Neurotrophin receptor-like protein immunoreactivity in human lymph nodes. Anat. Rec., 249: 226-232.
37. Gold, R., Hartung, H.P. and Lassmann, H. (1997) T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci., 20: 399-404.
38. Haase, G., Pettmann, B., Vigne, E., Castelnau-Ptakhine, L., Schmalbruch, H. and Kahn, A. (1998) Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: therapeutic effects and mechanisms of action. J. Neurol. Sci., 1: 97-105.
39. Hatmann, A., Mouatt-Prigent, A., Vila, M., Abbas, N., Perier, C., Faucheux, B.A., Vyas, S. and Hirsch, E.C. (2002) Increased expression and redistribution of the anti-apoptotic molecule Bcl-xL in Parkinson's disease. Neurobiol. Dis., 10: 28-32.
40. Hammarberg, H., Lidman, O., Lundberg, C., Eltayeb, S.Y., Gielen, A.W., Muhallab, S., Svenningsson, A., Linda, H., van der Meide, P.H., Cullheim, S., Olsson, T. and Piehl, F. (2000) Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-Infiltrating T and natural killer cells. J. Neurosci., 20: 5283-5291.
41. Hauben, E., Butovsky, O., Nevo, U., Yoles, E., Moalem, G., Agranov, E., Mor, F., Leibowitz-Amit, R., Pevsner, E., Akselrod, S., Neeman, M., Cohen, I.R. and Schwartz, M. (2000) Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci., 20: 6421-6430.
42. Hikawa, S., Kobayashi, H., Hikawa, N., Kusakabe, T., Hiruma, H., Takenaka, T., Tomita, T. and Kawakami, T. (2002) Expression of neutrophins and their receptors in peripheral lung cells of mice. Histochem. Cell Biol., 118: 51-58.
43. Hohlfeld, R., Kerschensteiner, M., Stadelmann, C., Lassmann, H. and Wekerle, H. (2000) The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J. Neuroimmunol., 107: 161-166.
44. Horigome, K., Pryor, J.C., Bullock, E.D. and Johnson, E.M. (1993) Mediator release from mast cells by nerve growth factor: neurotrophin specificity and receptor mediation. J. Biol. Chem., 268: 14881-14887.
45. Horigome, K., Bullock, E.D. and Johnson, E.M. (1994) Effect of nerve growth factor on rat peritoneal mast cells: survival promotion, and immediate-early gene induction. J. Biol. Chem., 269: 2695-2702.
46. Kalb, L.Y. (1995) Recovery from spinal cord injury: new approaches. Neuroscientist, 1: 321-327.
47. Kannan, Y., Ushio, H., Koyama, H., Okada, M., Oikawa, Y.T., Kaneko, M. and Matsuda, H. (1991) Nerve growth factor enhances survival, phagocytosis and superoxide production of murine neutrophils. Blood, 77: 1320-1325.
48. Kannan, Y., Usami, K., Okada, M., Shimizu, S. and Matsuda, H. (1992) Nerve growth factor suppresses apoptosis of murine neutrophils. Biochem. Biophys. Res. Commun., 186: 1050-1056.
49. Kaplan, D.R. and Stephens, R.M. (1994) Neurotrophin signal transduction by the Trk receptor. J. Neurobiol., 25: 1404-1417.
50. Kawamoto, K., Okada, T., Kannan, Y., Ushio, H., Matsumoto, M. and Matsuda, H. (1995) Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor. Blood, 86: 4638-4644.
51. Kipnis, J., Yoles, E., Porat, Z., Cohen, A., Mor, F., Sela, M., Cohen, I.R. and Schwartz, M. (2000) T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc. Natl. Acad. Sci. USA, 97: 7446-7451.
52. Knusel, B. and Hefti, F. (1992) K-252 compounds: modulators of neurotrophin signal transduction. J. Neurochem., 59: 1987-1996.
53. Kobayashi, H., Gleich, G.J., Butterfield, J.H. and Kita, H. (2002) Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood, 99: 2214-2220.
54. La Sala, A., Corinti, S., Federici, M., Saragovi, H.U. and Girolomoni, G. (2000) Ligand activation of nerve growth factor receptor trkA protects monocytes from apoptosis. J. Leukoc. Biol., 68: 104-110.
55. Lambiase, A., Bracci-Laudiero, L., Bonini, S., Bonini, S., Starace, G., D'Elios, M., De Carli, M. and Aloe, L. (1997) Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J. Allergy. Clin. Immunoly., 100: 408-414.
56. Laurenzi, M.A., Beccari, T., Stenke, L., Sjolinder, M., Stinchi, S. and Lindgren, J.A. (1998) Expression of mRNA encoding neutrophins and neutrophin receptors in human granulocytes and bone marrow cells-enhanced neurotrophin-4 expression induced by LTB4. J. Leukoc. Biol., 64: 228-234.
57. 252a and staurosporine microbial alkaloid toxins as prototype of neurotrophic drugs. In: B.R. Singh and A.T. Tu (Eds.), Natural Toxins II. Plenum Press, New York, pp. 367-377.
58. Lazarovici, P., Matsuda, Y., Kaplan, D. and Guroff, G. (1997) The protein kinase inhibitors K-252a and staurosporine as modifiers of neurotrophin receptor signal transduction. In: Y. Gutman and P. Lazarovici (Eds.), Cellular and Molecular Mechanisms of Toxin Action: Toxins and Signal Transduction, Vol. 1, Harwood Academic Publishers, Amsterdam, pp. 69-94.
59. Lee, R., Kermani, P., Teng, K.K. and Hempstead, B.L. (2001) Regulation of cell survival by secreted proneurotrophins. Science, 294: 1945-1948.
60. Leon, A., Buriani, A., Dal Toso, R., Fabris, M., Romanello, S., Aloe, L. and Levi-Montalcini, R. (1994) Mast cells synthesize, store, and release nerve growth factor. Proc. Natl. Acad. Sci. USA, 91: 3739-3743.
61. Lotan, M. and Schwartz, M. (1994) Cross talk between the immune system and the nerve system in response to injury: implications for regeneration. FASEB J., 8: 1026-1033.
62. MacMicking, J., Xie, Q.W. and Nathan, C. (1997) Nitric oxide and macrophage function. Annu. Rev. Immunol., 15: 323-350.
63. Manning, P.T., Russell, J.H., Simmons, B. and Johnson, E.M. (1985) Protection from guanethidine-induced neuronal destruction by nerve growth factor: effect of NGF on immune function. Brain Res., 340: 61-69.
64. Martin, R. (1997) Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies. J. Neural. Transm. Suppl., 49: 53-67.
65. Matsuda, H., Coughlin, M.D., Bienenstock, J. and Denburg, J.A. (1988a) Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc. Natl. Acad. Sci. USA, 85: 6508-6512.
66. Matsuda, H., Switzer, J., Coughlin, M.D., Bienenstock, J. and Denburg, J.A. (1988b) Human basophilic cell differentiation promoted by 2.5S nerve growth factor. Int. Arch. Allergy. Appl. Immunol., 86: 453-457.
67. Mautes, A.E., Weinzierl, M.R., Donovan, F. and Noble, L.J. (2000) Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys. Ther., 80: 673-687.
68. Melamed, I., Turner, C.E., Aktories, K., Kaplan, D.R. and Gelfand, E.W. (1995) Nerve growth factor trigges microfilament assembly and paxillin phosphorylation in human B lymphocytes. J. Exp. Med., 181: 1071-1079.
69. trk. Eur. J. Immunol., 26: 1985-1992.
70. Minagar, A., Shapshak, P., Fujimura, R., Ownby, R., Heyes, M. and Eisdorfer, C. (2002) The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J. Neurol. Sci., 202: 13-23.
71. Mizuma, H., Takagi, K., Miyake, K., Takagi, N., Ishida, K., Takeo, S., Nitta, A., Nomoto, H., Furukawa, Y. and Furukawa, S. (1999) Microsphere embolism-induced elevation of nerve growth factor level and appearance of nerve growth factor immunoreactivity in activated T-lymphocytes in the rat brain. J. Neurosci. Res., 55: 749-761.
72. Moalem, G., Monsonego, A., Shani, Y., Cohen, I.R. and Schwartz, M. (1999a) Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J., 13: 1207-1217.
73. Moalem, G., Leibowitz-Amit, R., Yoles, E., Mor, F., Cohen, I.R. and Schwartz, M. (1999b) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med., 5: 49-55.
74. Moalem, G., Gdalyahu, A., Shani, Y., Otten, U., Lazarovici, P., Cohen, I.R. and Schwartz, M. (2000) Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J. Autoimmun., 15: 331-345.
75. Muhallab, S., Lundberg, C., Gielen, A.W., Lidman, O., Svenningsson, A., Piehl, F. and Olsson, T. (2002) Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis. Scand. J. Immunol., 55: 264-273.
76. Nakagawara, A. (2001) Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett., 169: 107-114.
77. Noga, O., Englmann, C., Hanf, G., Grutzkau, A., Guhl, S. and Kunkel, G. (2002) Activation of the specific neurotrophin receptors TrkA, TrkB and TrkC influences the function of eosinophils. Clin. Exp. Allergy, 32: 1348-1354.
78. Ochs, G., Penn, R.D., York, M., Giess, R., Beck, M., Tonn, J., Haigh, J., Malta, E., Traub, M., Sendtner, M., Toyka, K.V. (2000) A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler. Other Motor Neuron Disord., 1: 201-206.
79. Okano, H., Yoshizaki, T., Shimazaki, T. and Sawamoto, K. (2002) Isolation and transplantation of dopaminergic neurons and neural stem cells. Parkinsonism Relat. Disord., 9: 23-28.
80. Ota, K., Matsui, M., Milford, E.L., Mackin, G.A., Weiner, H.L. and Hafler, D.A. (1990) T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature, 346: 183-187.
81. Otten, U., Ehrhard, P. and Peck, R. (1989) Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc. Natl. Acad. Sci. USA, 89: 10059-10063.
82. Otten, U. and Gadient, R.A. (1995) Neurotrophins and cytokines-intermediaries between the immune and nervous systems. Int. J. Dev. Neurosci., 13: 147-151.
83. Patapoutian, A. and Reichardt, L. (2001) Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol., 11: 272-280.
84. Popovich, P.G. and Jones, T.B. (2003) Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol. Sci., 24: 13-17.
85. Rasouly, D., Rahamim, E., Lester, D., Matsuda, Y. and Lazarovici, P. (1992) Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition. Mol. Pharmacol., 42: 35-43.
86. Ricci, A., Greco, S., Mariotta, S., Felici, L., Amenta, F. and Bronzetti, E. (2002) Neurotrophin and neurotrophin receptor expression in alveolar macrophages: an immunocytochemical study. Growth Factors, 18: 193-202.
87. Roitt, I., Brostoff, J. and Male, D. (2001) Immunology. Mosby, Philadelphia, pp. 15-64.
88. Roux, P.P., Dorval, G., Boudreau, M., Angers-Loustau, A., Morris, S.J., Makkerh, J. and Barker, P.A. (2002) K252a and CEP1347 are neuroprotective compounds that inhibit mixed-lineage kinase-3 and induce activation of Akt and ERK. J. Biol. Chem., 277: 49473-49480.
89. Ruth, D. and Melamed, E. (2002) New drugs in the future treatment of Parkinson's disease. J. Neurol., 249: 30-35.
90. Sawada, J., Itakura, A., Tanaka, A., Furusaka, T. and Matsuda, H. (2000) Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Blood, 95: 2052-2058.
91. Schenone, A., Gill, J.S., Zacharias, D.A. and Windebank, A.J. (1996) Expression of high- and low-affinity neutrophin receptors on human transformed B lymphocytes. J. Neuroimmunol., 64: 141-149.
92. Schori, H., Lantner, F., Shachar, I. and Schwartz, M. (2002) Severe immunodeficiency has opposite effects on neuronal survival in glutamate-susceptible and -resistant mice: adverse effect of B cells. J. Immunol., 169: 2861-2865.
93. Schwartz, M., Moalem, G., Leibowitz-Amit, R. and Cohen, I.R. (1999) Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci., 22: 295-299.
94. Schwartz, M. and Kipnis, J. (2001) Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol. Med., 7: 252-258.
95. Schwartz, M. and Moalem, G. (2001) Beneficial immune activity after CNS injury: prospects for vaccination. J. Neuroimmunol., 113: 185-192.
96. Serpe, C.J., Kohm, A.P., Huppenbauer, C.B., Sanders, V.M. and Jones, K.J. (1999) Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice. J. Neurosci., 19: RC7.
97. Serpe, C.J., Sanders, V.M. and Jones, K.J. (2000) Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice. J. Neurosci. Res., 62: 273-278.
98. Shoichet, M.S. and Winn, S.R. (2000) Cell delivery to the central nervous system. Adv. Drug Deliv. Rev., 42: 81-102.
99. Sin, A.Z., Roche, E.M., Togias, A., Lichtenstein, L.M. and Schroeder, J.T. (2001) Nerve growth factor or IL-3 induces more IL-13 production from basophils of allergic subjects than from basophils of nonallergic subjects. J. Allergy Clin. Immunol., 108: 387-393.
100. Skaper, S.D. and Walsh, F.S. (1998) Neurotrophic molecules: strategies for designing effective therapeutic molecules in neurodegeneration. Mol. Cell Neurosci., 12: 179-193.
101. Skaper, S.D., Pollock, M. and Facci, L. (2001) Mast cells differentially express and release active high molecular weight neurotrophins. Brain Res. Mol. Brain Res., 97: 177-185.
102. Solomon, A., Aloe, L., Pe'er, J., Frucht-Pery, J., Bonini, S., Bonini, S. and Levi-Schaffer, F. (1998) Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J. Allergy Clin. Immunol., 102: 454-460.
103. Soontornniyomkij, V., Wang, G., Pittman, C.A., Wiley, C.A. and Achim, C.L. (1998) Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis. Neurophatol. Appl. Neurobiol., 24: 453-460.
104. Stadelmann, C., Kerschensteiner, M., Misgeld, T., Bruck, W., Hohlfeld, R. and Lassmann, H. (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain, 125: 75-85.
105. Storch, A. and Schwarz, J. (2002) Neural stem cells and neurodegeneration. Curr. Opin. Investig. Drugs, 3: 774-781.
106. Susaki, Y., Shimizu, S., Katakura, K., Watanabe, N., Kawamoto, K., Matsumoto, M., Tsudzuki, M., Furusaka, T., Kitumara, Y. and Matsuda, H. (1996) Functional properties of murine macrophages promoted by nerve growth factor. Blood, 88: 4630-4637.
107. Tam, S.Y., Tsai, M., Yamaguchi, M., Yano, K., Butterfield, J.H. and Galli, S.J. (1997) Expression of functional trkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood, 90: 1807-1820.
108. Tonra, J.R., Curtis, R., Wong, V., Cliffer, K.D., Park, J.S., Timmes, A., Nguyen, T., Lindsay, R.M., Acheson, A., DiStefano, P.S. (1998) Axotomy upregulates the anterograde transport and expression of brain-derived neurotrophic factor by sensory neurons. J. Neurosci., 18: 4374-4383.
109. Thorpe, L.W. and Perez-Polo, J.R. (1987) The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J. Neurosci. Res., 18: 134-139.
110. Weiss, J.H., Hartley, D.M., Koh, J. and Choi, D.W. (1990) The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science, 247: 1474-1477.
111. Ulvestad, E., Williams, K., Bjerkvig, R., Tiekotter, K., Antel, J. and Matre, R. (1994) Human microglial cells have phenotypic and functional characteristics common with both macrophages and dendritic antigen-presenting cells. J. Leukoc. Biol., 56: 732-740.
112. Xiang, Z. and Nilsson, G. (2000) IgE receptor-mediated release of nerve growth factor by mast cells. Clin. Exp. Allergy, 30: 1379-1386.
113. Yoles, E. and Schwartz, M. (1998) Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp. Neurol., 153: 1-7.
114. Ziemssen, T., Kumpfel, T., Klinkert, W.E.F., Neuhaus, O. and Hohlfeld, R. (2002) Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain, 125: 2381-2391.
115. Zuddas, A., Oberto, G., Vaglini, F., Fascetti, F., Fornai, F. and Corsini, G.U. (1992) MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonisms in primates. J. Neurochem., 59: 733-739.